Follow the BioNexus Gene Lab Corp share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the authority of SEC (Form 4). The latest transaction was filed on 14 August 2026 (Attribution). Among the most active insiders: Bin Abdul Hamid Muhammad Azrul. Every trade is free.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 28,690 of 28,985 companies
7.3
score / 100
Value
4
Quality
11
FCF yld-43%
Earn yld-68%
EV/EBITDA·
ROE-34%
Gross mgn15%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.